跳至主要内容
临床试验/NCT05720338
NCT05720338招募中3 期

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy: A Randomized Control Trial

Case Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 234 人开始时间: 2023年4月13日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
招募中
入组人数
234
试验地点
1
主要终点
Composite endpoint comparison

研究概览

简要总结

The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drainage with respect to a composite post-operative complications of Grade B or C Postoperative pancreatic fistula (POPF), readmission, or organ space surgical site infection following a distal pancreatectomy.

详细描述

Pancreatic resections are commonly performed across the United States, yet still represent one of the most morbid abdominal operations in the country, with postoperative mortality as high as 7.7%. Distal pancreatectomy (DP) represents one of the most common approaches to pancreatic resection and is typically used for tumors of the pancreatic body or tail. This operation is known to have a high historic morbidity, with reports of overall morbidity between 12-52%. Common complications include intraabdominal abscess and surgical site infection. Postoperative pancreatic fistula (POPF) represents the most common complication following partial pancreatic resection, with rates reported with rates as high as 30% in multiple large retrospective studies. Multiple strategies to prevent postoperative pancreatic leak following distal pancreatectomy have been studied. One of the outstanding questions that remains is regarding the need for routine intraperitoneal drainage following DP, particularly since the advent of reinforced staple technology. This study aims to determine if intraperitoneal drainage is necessary following DP. This study will compare groups using a composite endpoint of complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must be undergoing a scheduled distal pancreatectomy (with or without concurrent splenectomy)
  • Age ≥18 years
  • Subjects must have the ability to understand and the willingness to sign a written informed consent document.

排除标准

  • Patients < 18 years old
  • Patients who are pregnant
  • Patients with a history of previous pancreatic surgery
  • Patients with a history of prior gastric resection, gastric bypass or sleeve gastrectomy
  • Patients with prior cystogastrostomy procedure
  • Patients who have failed prior endoscopic intervention or ultrasound due to esophageal or other gastrointestinal stricture
  • Patients with Type 3 or Type 4 Paraesophageal Hernia noted either on pre-operative imaging or intra-operatively
  • Patients undergoing concurrent resection of organs other than the pancreas or spleen or gallbladder
  • Patients who undergo oversewing of the pancreatic transection margin
  • Patients with unexpected intraoperative bleeding or adhesive disease which deem it unsafe to proceed without an intraabdominal drain
  • Patients who are unable to provide informed consent

研究组 & 干预措施

Standard of care

Active Comparator

Intraperitoneal drain will be placed near the pancreatic resection margin, which is the routine standard of care.

干预措施: 19 French Blake Drain (Device)

Omitting Standard of Care

No Intervention

No intraperitoneal drain will be placed in the participants, which omits the routine standard of care.

结局指标

主要结局

Composite endpoint comparison

时间窗: Within 90 days of surgery

Comparison between groups using a composite endpoint of complications that includes presence of Grade B POPF

次要结局

  • Rates of endoscopic drainage vs percutaneous drainage of Grade B POPF(90-day post operative time point)
  • Cost analysis for overall healthcare costs(At day 90 postoperative)
  • Hospital Length of Stay(90-day post operative time point)
  • Quality of Life Score(At day 90 postoperative)
  • Quality of Life Score(At day 14 postoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验